thewealthnet

Pfizer vaccine: Is the good news now priced in?

News Team, 10/11/2020

Markets reacted dramatically yesterday (9 November) as Pfizer announced it had developed a Covid-19 vaccine which prevents 90 percent of cases.

Investors pivoted back towards stocks that have been unloved this year, in sectors which were hit hardest by the virus.

James Athey, an investment director at Aberdeen Standard Investments described some of the moves as “eye-watering”, as Pfizer and its collaborator BioNTech announced a vaccine even more effective than t...


Continue reading this article...


Start a free trial now for access to breaking news and cutting edge analysis of the wealth management industry.







You are currently not logged in,
login to view the full article
start by clicking this button.





Need a subscription,
fill out the form here or
contact subs@thewealthnet.com